Depo-Provera Contraceptive Injection (FDA Prescribing Information)

Pharmacia & Upjohn Company

Depo-Provera Contraceptive Injection (FDA Prescribing Information)

Pharmacia & Upjohn Company, 2004

Source

Abstract

No abstract available for this article.

Topics

Contraception/Comparison > Side Effects > Hormonal Contraception Contraception/Comparison > Effectiveness > Typical Use

depo-provera prescribing information, medroxyprogesterone injectable contraceptive, depot medroxyprogesterone acetate fda, dmpa contraceptive injection, depo provera side effects, injectable hormonal contraception, depo shot package insert, medroxyprogesterone contraceptive label

Cite this article

Pharmacia & Upjohn Company (2004). *Depo-Provera Contraceptive Injection (FDA Prescribing Information)*.

Depo-Provera Contraceptive Injection (FDA Prescribing Information)

Abstract

Topics

Cite this article

Related articles

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation

Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis

Use of contraception and use of family planning services in the United States: 1982-2002